Detalhe da pesquisa
1.
Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing.
J Antimicrob Chemother
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758205
2.
Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis.
Clin Infect Dis
; 73(9): e3365-e3373, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856694
3.
The development and validation of a novel LC-MS/MS method for the quantification of cenicriviroc in human plasma and cerebrospinal fluid.
Biomed Chromatogr
; 34(1): e4711, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629375
4.
Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks.
Clin Infect Dis
; 62(6): 675-682, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26646680
5.
Cerebrospinal fluid exposure of cenicriviroc in HIV-positive individuals with cognitive impairment.
Br J Clin Pharmacol
; 85(5): 1039-1040, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30834549
6.
A novel LC-MS/MS method for the determination of favipiravir ribofuranosyl-5'-triphosphate (T-705-RTP) in human peripheral mononuclear cells.
J Pharm Biomed Anal
; 245: 116155, 2024 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652938
7.
Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC-MS.
Bioanalysis
; 15(13): 739-756, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293769
8.
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.
Clin Pharmacol Ther
; 111(3): 585-594, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699618
9.
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir.
J Pharm Biomed Anal
; 78-79: 217-23, 2013 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23501442